In a murine model of BCR-FGFR1, Roumiantsev et al. [14] demonstrated that the BCR-FGFR1 fusion kinase induced a CML-like neoplasm devoid of T-cell lymphomas. The gene discussed is FGFR1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.